Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) insider Peter Soparkar purchased 21,925 shares of Adverum Biotechnologies stock in a transaction that occurred on Tuesday, April 19th. The shares were bought at an average price of $1.14 per share, with a total value of $24,994.50. Following the completion of the transaction, the insider now owns 280,556 […]
Brokerages expect Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) to report ($0.34) earnings per share for the current fiscal quarter, according to Zacks. Zero analysts have made estimates for Adverum Biotechnologies’ earnings. The highest EPS estimate is ($0.33) and the lowest is ($0.35). Adverum Biotechnologies posted earnings of ($0.29) per share in the same quarter […]
StockNews.com started coverage on shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) in a report released on Thursday. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, Zacks Investment Research raised shares of Adverum Biotechnologies from a hold rating to a buy rating and set a $2.00 price target for the company […]
Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) announced its quarterly earnings data on Tuesday. The biotechnology company reported ($0.35) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.34) by ($0.01), MarketWatch Earnings reports. Shares of NASDAQ ADVM opened at $1.34 on Thursday. Adverum Biotechnologies has a twelve month low of $1.21 and a twelve […]
Equities analysts predict that Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Rating) will announce earnings per share (EPS) of ($0.42) for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Adverum Biotechnologies’ earnings, with the lowest EPS estimate coming in at ($0.43) and the highest estimate coming in at ($0.41). Adverum Biotechnologies […]